News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Milos Grujic: Patient-Reported Outcomes with Talazoparib plus Enzalutamide
Miloš Grujić//LinkedIn
Apr 19, 2025, 01:19

Milos Grujic: Patient-Reported Outcomes with Talazoparib plus Enzalutamide

Milos Grujic, Head of Department of the subspecialist cabinets at the Center for Radiation Oncology at the University Clinical Center Kragujevac, shared a post on X:

“In TALAPRO-2, Talazoparib plus Enzalutamide significantly delayed QoL deterioration in mCRPC patients with HRR alterations.
Median: 27.1 vs 19.3 months
HR: 0.69 | p=0.032
Better QoL, longer control.
Lancet Oncology 2025.”

Milos Grujic: Patient-Reported Outcomes with Talazoparib plus Enzalutamide

 

cancer Enzalutamide Lancet Oncology Miloš Grujić OncoDaily Oncology Talazoparib
Special Coverage
Oncolibrary
Jun 16, 2025, 10:42
New Paper Alert: Relacorilant Plus Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer (ROSELLA Trial)
Blog
Jun 16, 2025, 10:41
Luca Boldrini: MRI-Guided Stereotactic Radiotherapy for Oligometastatic Peritoneal Carcinomatosis
Blog
Jun 16, 2025, 10:28
ACREOL Global Honors Fathers in Palliative Care on Father’s Day
Blog
Jun 16, 2025, 10:11
Join Breast Cancer Experts on June 16 For a Free Virtual Breast Cancer Forum - City of Hope
Blog
Jun 16, 2025, 09:49
The Abstract Submission Portal For The 67th ASH Annual Meeting and Exposition is Open - The American Society of Hematology
Blog
Jun 16, 2025, 09:39
Nikki Audia: Father’s Day in Oncology - Strength Woven Through Every Fight
Science
Jun 16, 2025, 09:38
Elvina Almuradova: ROSELLA Phase III - Adding Relacorilant to Nab-Paclitaxel in Platinum-Resistant Ovarian Cancer
Blog
Jun 16, 2025, 09:33
Sheraz Azhar: Wrapping up Day 1 of the UKOF 2025
Blog
Jun 16, 2025, 09:14
Thomas Miller: Unlocking Smarter BCL-2 Inhibitor Therapies After EHA2025
Insight
Jun 16, 2025, 09:02
Aaron Goodman Announces Nevada's First CAR-T Treatment Launch
Blog
Jun 16, 2025, 08:50
What Does it Really Take to Make Clinical Trials Inclusive? - Syneos Health Clinical Solutions
Insight
Jun 16, 2025, 08:12
2nd Synergies Forum on Cancer Policy, Research and Funding Strategies Organized by ELLOK